Fifth Third Bancorp Increases Stock Position in Astera Labs, Inc. $ALAB

Fifth Third Bancorp raised its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 122,693.2% in the 1st quarter, HoldingsChannel.com reports. The fund owned 54,029 shares of the company’s stock after purchasing an additional 53,985 shares during the period. Fifth Third Bancorp’s holdings in Astera Labs were worth $5,922,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Reflection Asset Management acquired a new stake in shares of Astera Labs during the fourth quarter worth about $25,000. Smartleaf Asset Management LLC lifted its holdings in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank boosted its position in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the period. Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs in the 4th quarter valued at about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs during the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on ALAB. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Morgan Stanley raised their target price on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Stifel Nicolaus upped their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $275.75.

Astera Labs Stock Down 8.8%

NASDAQ ALAB opened at $319.74 on Friday. The firm has a market cap of $54.81 billion, a P/E ratio of 216.04, a P/E/G ratio of 3.95 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $90.90 and a 52-week high of $499.48. The business’s 50-day moving average price is $347.25 and its 200 day moving average price is $220.00.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period in the prior year, the business earned $0.33 EPS. The firm’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current year.

Insider Activity

In related news, Director Manuel Alba sold 136,974 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the completion of the transaction, the chief executive officer owned 3,929,183 shares in the company, valued at approximately $786,465,269.28. This trade represents a 3.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,700,432 shares of company stock valued at $449,062,723. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.